Informational Tool for Smoking Cessation in COPD Patients

Last updated: March 18, 2025
Sponsor: Hopital Nord Franche-Comte
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bronchiectasis

Chronic Bronchitis

Emphysema

Treatment

informational intervention

Clinical Study ID

NCT06872450
2024-11-IMPACT BPCO
  • Ages > 18
  • All Genders

Study Summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3

  • People treated at HNFC

  • Smokers

Exclusion

Exclusion Criteria:

  • People with cognitive disorders compromising comprehension and completion of thestudy

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: informational intervention
Phase:
Study Start date:
February 14, 2025
Estimated Completion Date:
June 14, 2025

Study Description

implementing a tool in the form of an informational intervention with a specific motivational intervention

Connect with a study center

  • Hôpital Nord Franche-comté

    Trevenans, 90400
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.